Decipher Genomic Classifier of Early Prostate Cancer and Underlying Transcriptomic Profile

At the 2025 American Society of Clinical Oncology Genitourinary Cancers Symposium, Daniel Keizman, MD, of Tel-Aviv Sourasky Medical Center, showcases his research on the Decipher genomic classifier of early prostate cancer, and underlying transcriptomic profiles for American versus non-American populations.

He elaborates on the key differences in the transcriptomic profiles observed between these populations, as well as how these differences may influence the clinical utility of Decipher in diverse patient populations.